Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
471.00    -12.30 (-2.55%)
Bid:
473.40
Ask:
473.60
Spread: 0.20 (0.042%)
Market Cap: £5.87b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Trading update – full year guidance confirmed

14 Nov 2025 07:00

RNS Number : 5088H
Melrose Industries PLC
14 November 2025
 

14 November 2025

 

MELROSE INDUSTRIES PLC

 

Trading update - full year guidance confirmed

 

Melrose Industries PLC ("Melrose" or "the Group") announces the following trading update for the four months from 1 July 2025 to 31 October 2025 ("the Period"). Growth rates are calculated at constant currency and exclude the impact of exited businesses[1].

 

Peter Dilnot, Chief Executive Officer of Melrose said:

 

"We have delivered another strong performance during this transformational year with continued positive momentum in both our civil and defence businesses. Our focus for the rest of the year remains on ramping up production and delivering for our customers. With strong demand, differentiated technologies and established positions on all the world's leading aircraft, we are well placed to deliver growth and increasing free cash flow this year and into the future."

 

Group performance

 

Group revenue grew by 14%, with Engines up 28%, driven by a strong performance in both OE and the aftermarket, and Structures up 5%. Adjusted operating profit was significantly higher than the comparative period and in line with our expectations.

 

End markets

 

In civil aerospace, record backlogs are underpinning the OE production ramp. Air traffic growth and low retirement rates continue to support the aftermarket. Geopolitical uncertainty is driving a step change in defence spending, which is providing a number of new growth opportunities for the Group. The UK/US and EU/US tariff agreements have been welcomed by market participants, providing greater certainty for the civil aerospace industry.

 

Engines

 

In Engines, OE growth was particularly strong, up 35%, driven by our RRSP portfolio across both narrowbody and widebody platforms. Aftermarket grew by 22% and included a return to robust growth for our parts repair business. Engines' performance includes continued momentum from the increase in OE production rates and the recovery from tariff-related uncertainty and backlogs in the first half.

 

Looking ahead, the division is well placed to meet the ongoing industry ramp-up from its established positions and to support our customers on new technologies and the next generation of engines.

 

Structures

Structures revenue was up 5%, ahead of the growth rate at the half year. We saw encouraging growth in Defence, reflecting strong demand coupled with our business improvement actions and the work we have done on sustainable pricing across the business. The performance in Civil continued to be constrained by well-publicised customer supply chain issues.

 

We are well positioned to support our OEM customers as build rates continue to grow over the next few years to meet record backlogs in both civil and defence.

 

Outlook and full year guidance

 

During the remainder of the financial year, we will continue to focus on delivering for our customers in what is the industry's most significant trading period. Our guidance for the full year remains unchanged:

 

·

Revenue range of £3.425 billion to £3.575 billion

·

Adjusted operating profit range (post PLC costs of £30 million) of £620 million to £650 million

·

Free cash flow generation of £100+ million (after interest and tax)

·

Guidance based on US$ = 1.335 average exchange rate[2]; guidance continues to exclude the direct and indirect impact of any new or changed tariffs

 

Melrose will publish full year results for 2025 on Friday 27 February 2026.

 

Enquiries:

 

Investor Relations:

 

Mat Wootton: +44 (0) 7483 961 233; mat.wootton@melroseplc.net

 

Media:

 

Simon Sporborg, Tom Pigott

 

Brunswick: +44 (0) 207 404 5959; melrose@brunswickgroup.com

 

 


[1] Exited businesses contributed £4 million of sales in the period 1 July 2024 to 31 October 2024

[2] A 1% change in the USD or Euro in isolation would result in adjusted operating profit moving by £6 million and £0.5 million respectively; and gross debt by £11 million and £3 million respectively. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFLFADEISEEF
Date   Source Headline
19th Jun 20261:12 pmRNSTR-1: Standard Form-Notification of Major Holdings
18th Jun 20267:00 amRNSTR-1:Standard form-notification of major holdings
16th Jun 20263:57 pmRNSNotifications of Transactions of PDMR
16th Jun 20267:18 amRNSTR-1: Notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202610:58 amRNSNotifications of Transactions of PDMR
12th Jun 20269:54 amRNSTR-1: Standard Form-Notification of Major Holdings
10th Jun 202610:43 amRNSTR1 - notification of major holdings
8th Jun 202612:25 pmRNSTR1 - Notification of Major Holdings
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20269:07 amRNSTR-1: Standard Form-Notification of Major Holdings
1st Jun 20269:02 amRNSTR1 - Notification of major holdings
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 202610:34 amRNSTR-1: Notification of major holdings
27th May 20264:26 pmRNSPDMR Announcement
27th May 20268:32 amRNSUpdate on Garden Grove facility in California
26th May 20267:09 amRNSOngoing incident at Garden Grove facility
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTR-1: Standard Form-Notification of Major Holdings
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTR-1: Standard form for notification
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20269:36 amRNSNotifications of Transactions of PDMR
5th May 20264:43 pmRNSNotifications of Transactions of PDMR
5th May 20264:23 pmRNSTransaction in Own Shares
5th May 20267:00 amRNSDirector Change / CFO Appointment
1st May 20268:26 amRNSDirector/PDMR Shareholding
29th Apr 20262:15 pmRNSResults of AGM
29th Apr 20267:00 amRNSAGM TRADING UPDATE
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20269:18 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:09 amRNSNotifications of Transactions of PDMR
23rd Mar 20264:05 pmRNSAnnual Report and Notice of Annual General Meeting
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20269:52 amRNSNotification of Transactions of PDMR
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20263:19 pmRNSNotification of Transactions of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.